Aralez Pharmaceuticals R&D Inc.
11
Martin Glenn
08/10/2018
06/28/2019
Yes
v
| MEGA, JtAdm, CLMAGT |
Assigned to: Judge Martin Glenn Chapter 11 Voluntary Asset |
|
Debtor Aralez Pharmaceuticals R&D Inc.
400 Alexander Park Drive Princeton, NJ 08540 MERCER-NJ Tax ID / EIN: 47-5229731 fka Aralez R&D Inc. |
represented by |
Paul V. Shalhoub
Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, NY 10019-6099 (212) 728-8764 Fax : (212) 728-8111 Email: maosbny@willkie.com Robin Spigel
Willkie Far & Gallagher LLP 787 Seventh Avenue New York, NY 10019-6099 212 728-8822 Fax : 212 728-8111 Email: maosbny@willkie.com |
U.S. Trustee United States Trustee
Office of the United States Trustee U.S. Federal Office Building 201 Varick Street, Room 1006 New York, NY 10014 (212) 510-0500 |
| |
Claims and Noticing Agent Prime Clerk LLC Claims Agent
Attn: Shai Y. Waisman 830 3rd Avenue, 9th Floor www.primeclerk.com New York, NY 10022 (212) 257-5450 |
| Date Filed | # | Docket Text |
|---|---|---|
| 08/16/2018 | Claims and Noticing Agent, Prime Clerk LLC Claims Agent, added to the case. (Richards, Beverly). (Entered: 08/16/2018) | |
| 08/14/2018 | An order has been entered in this case directing the procedural consolidation and joint administration of the chapter 11 cases of Aralez Pharmaceuticals US Inc. and its affiliates that have concurrently commenced chapter 11 cases. The docket in the chapter 11 case of Aralez Pharmaceuticals US Inc., Case No. 18-12425 (MG), should be consulted for all matters affecting this case. (Gomez, Jessica). (Entered: 08/14/2018) | |
| 08/14/2018 | 5 | Order signed on 8/14/2018 Granting Motion Directing Joint Administration of Related Chapter 11 Cases Under The Lead Case of Aralez Pharmaceuticals US Inc., Case No. 18-12425(MG) (Related Doc # 2). (Gomez, Jessica) (Entered: 08/14/2018) |
| 08/10/2018 | Judge Martin Glenn added to the case. (Porter, Minnie). (Entered: 08/10/2018) | |
| 08/10/2018 | 4 | Declaration of Michael Kaseta in Support of Chapter 11 Petitions and First Day Pleadings filed by Robin Spigel on behalf of Aralez Pharmaceuticals R&D Inc.. (Spigel, Robin) (Entered: 08/10/2018) |
| 08/10/2018 | 3 | Motion to Extend Deadline to File Schedules or Provide Required Information / Debtors' Motion for Order Extending Deadline for Debtors to File their Schedules of Assets and Liabilities and Statements of Financial Affairs filed by Robin Spigel on behalf of Aralez Pharmaceuticals R&D Inc.. (Spigel, Robin) (Entered: 08/10/2018) |
| 08/10/2018 | Receipt of Voluntary Petition (Chapter 11)(18-12428) [misc,824] (1717.00) Filing Fee. Receipt number 12714853. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 08/10/2018) | |
| 08/10/2018 | 2 | Motion for Joint Administration / Debtors' Motion for Order Authorizing Joint Administration Pursuant to Rule 1015(b) of the Federal Rules of Bankruptcy Procedure filed by Robin Spigel on behalf of Aralez Pharmaceuticals R&D Inc.. (Spigel, Robin) (Entered: 08/10/2018) |
| 08/10/2018 | 1 | Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Filed by Paul V. Shalhoub of Willkie Farr & Gallagher LLP on behalf of Aralez Pharmaceuticals R&D Inc.. (Shalhoub, Paul) (Entered: 08/10/2018) |